New oral drug cocktail aims to tame Tough-to-Treat leukemia
NCT ID NCT04774393
Summary
This study is testing a combination of three oral drugs to treat acute myeloid leukemia (AML) that has come back or hasn't responded to previous treatments. The goal is to see if this combination is safe and can help control the cancer. The trial will enroll about 84 adults with specific genetic mutations in their cancer cells. Patients will take the drugs in repeating 28-day cycles for up to a year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.